Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01154920 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cetuximab
DRUG: Docetaxel
DRUG: Cisplatin
DRUG: Fluorouracil
RADIATION: Radiotherapy (RT)
OTHER: Chemotherapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]